Comerica Bank Novo Cure LTD Transaction History

Comerica Bank

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 22, 2021	SELL	$116.17 - $194.55 $348,858 - $584,233	-3,003 Closed	0 $0
Q2 2021 Aug 26, 2021	SELL	$130.4 - $225.58 $20,472 - $35,416	-157 Reduced 4.97%	3,003 $666,000
Q1 2021 Apr 28, 2021	SELL	$124.11 - $190.17 $46,293 - $70,933	-373 Reduced 10.56%	3,160 $417,000
Q4 2020 Jan 28, 2021	SELL	$112.16 - $174.14 $18,730 - $29,081	-167 Reduced 4.51%	3,533 $611,000
Q3 2020 Oct 30, 2020	SELL	$58.05 - $111.31 $1,857 - $3,561	-32 Reduced 0.86%	3,700 $411,000
Q2 2020 Jul 31, 2020	BUY	$57.2 - $74.41 $36,093 - $46,952	631 Added 20.35%	3,732 $221,000
Q1 2020 May 01, 2020	BUY	$57.05 - $95.75 $6,617 - $11,107	116 Added 3.89%	3,101 $208,000
Q4 2019 Feb 07, 2020	BUY	$68.3 - $93.8 $203,875 - $279,993	2,985 New	2,985 $251,000

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.37B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

Stay updated on Comerica Bank with notifications on news.